Foster & Motley Inc. Increases Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Foster & Motley Inc. increased its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 388.8% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 2,351 shares of the medical equipment provider’s stock after acquiring an additional 1,870 shares during the quarter. Foster & Motley Inc.’s holdings in Intuitive Surgical were worth $1,227,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Berbice Capital Management LLC purchased a new stake in Intuitive Surgical in the fourth quarter valued at $26,000. Godsey & Gibb Inc. raised its position in Intuitive Surgical by 140.0% in the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after purchasing an additional 35 shares during the period. MidAtlantic Capital Management Inc. purchased a new stake in Intuitive Surgical in the third quarter valued at $33,000. Decker Retirement Planning Inc. purchased a new stake in Intuitive Surgical in the fourth quarter valued at $36,000. Finally, Capital Performance Advisors LLP purchased a new stake in Intuitive Surgical in the third quarter valued at $38,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insiders Place Their Bets

In other Intuitive Surgical news, Director Amal M. Johnson sold 4,635 shares of Intuitive Surgical stock in a transaction dated Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the completion of the sale, the director now directly owns 12,275 shares of the company’s stock, valued at $6,955,015. The trade was a 27.41 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CFO Jamie Samath sold 94 shares of Intuitive Surgical stock in a transaction dated Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total value of $53,684.34. Following the sale, the chief financial officer now directly owns 2,630 shares of the company’s stock, valued at $1,502,019.30. This trade represents a 3.45 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 28,843 shares of company stock valued at $15,357,560 in the last ninety days. Insiders own 0.90% of the company’s stock.

Intuitive Surgical Price Performance

Shares of NASDAQ ISRG opened at $580.18 on Friday. The company has a market capitalization of $206.65 billion, a price-to-earnings ratio of 93.28, a price-to-earnings-growth ratio of 5.19 and a beta of 1.39. The business has a 50-day moving average of $549.32 and a two-hundred day moving average of $507.50. Intuitive Surgical, Inc. has a 1 year low of $364.17 and a 1 year high of $616.00.

Wall Street Analysts Forecast Growth

ISRG has been the topic of a number of research analyst reports. CICC Research initiated coverage on Intuitive Surgical in a research report on Monday. They issued a “neutral” rating and a $550.00 target price on the stock. Evercore ISI lifted their price objective on Intuitive Surgical from $490.00 to $530.00 in a research note on Monday. Jefferies Financial Group lifted their price objective on Intuitive Surgical from $475.00 to $575.00 in a research note on Monday. Wells Fargo & Company lifted their price objective on Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a research note on Friday, January 24th. Finally, Oppenheimer reaffirmed a “market perform” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have assigned a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $613.10.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.